Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data
Open accessThe DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
The Library of Integrated Network-based Cellular Signatures (LINCS) program is a national consortium funded by the NIH to generate a diverse and extensive reference library of cell-based perturbation-response signatures, along with novel data analytics tools to improve our understanding of human diseases at the systems level. In contrast to other large-scale data generation efforts, LINCS Data and Signature Generation Centers (DSGCs) employ a wide range of assay technologies cataloging diverse cellular responses. Integration of, and unified access to LINCS data has therefore been particularly challenging. The Big Data to Knowledge (BD2K) LINCS Data Coordination and Integration Center (DCIC) has developed data standards specifications, data processing pipelines, and a suite of end-user software tools to integrate and annotate LINCS-generated data, to make LINCS signatures searchable and usable for different types of users. Here, we describe the LINCS Data Portal (LDP) (http://lincsportal.ccs.miami.edu/), a unified web interface to access datasets generated by the LINCS DSGCs, and its underlying database, LINCS Data Registry (LDR). LINCS data served on the LDP contains extensive metadata and curated annotations. We highlight the features of the LDP user interface that is designed to enable search, browsing, exploration, download and analysis of LINCS data and related curated content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such datasets are currently not available from published comprehensive screens but are being collected in ongoing efforts such as the Library of Integrated Network-Based Cellular Signature (Koleti et al., 2018) program.”
From Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model (2018) · cites this paper as Koleti et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · cited 1×
“Standardized small molecules are currently cross-referenced to PubChem Compounds (17) (via CID), ChEMBL (18), ChEBI (13), and UniChem (https://www. ebi.ac.uk/unichem/), which provides cross-reference to 37 additional public databases.”
BackgroundChEBI: a database and ontology for chemical entities of biological interest
Degtyarenko, K., de Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A., Alcantara, R., Darsow, M., Guedj, M., & Ashburner, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm791 · Cited by 1,126
The Universal Protein Resource (UniProt): an expanding universe of protein information
Wu, C. H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj161 · Cited by 1,110
Implications of the Human Genome Project for Medical Science
Collins, F. S. (2001) · JAMA · doi:10.1001/jama.285.5.540 · Cited by 838
Systems biology in drug discovery
Butcher, E. C., Berg, E. L., & Kunkel, E. J. (2004) · Nature Biotechnology · doi:10.1038/nbt1017 · Cited by 605
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459 · cited 1×
“…of the Human Genome Project (1), increasingly powerful technologies for large-scale multi-omics profiling and integrative data analytics have transformed the ability to gain insights and model the complex and dynamic networks of molecules and biological processes involved in human disease (2).”
BackgroundNIH Molecular Libraries Initiative
Austin, C. P., Brady, L. S., Insel, T. R., & Collins, F. S. (2004) · Science · doi:10.1126/science.1105511 · Cited by 348
Poornima, P., Kumar, J. D., Zhao, Q., Blunder, M., & Efferth, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.018 · Cited by 248
Cited by
The Cellosaurus, a Cell-Line Knowledge Resource
Bairoch, A. (2018) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.18-2902-002 · Cited by 807
Machine and deep learning approaches for cancer drug repurposing
Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.011 · Cited by 274
Self-citationDeep learning for drug response prediction in cancer
Baptista, D., Ferreira, P. G., & Rocha, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 237
Wu, Y., & Xie, L. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.12.030 · Cited by 178
LINCS Data Portal 2.0: next generation access point for perturbation-response signatures
Stathias, V., Turner, J., Koleti, A., Vidovic, D., Cooper, D., Fazel-Najafabadi, M., Pilarczyk, M., Terryn, R., Chung, C., Umeano, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1023 · Cited by 161
Self-citationAn update on Drug Repurposing: Re-written saga of the drug’s fate
GNS, H. S., GR, S., Murahari, M., & Krishnamurthy, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.127 · Cited by 161
Yang, C. G., Zhang, H., Chen, M., Wang, S., Qian, R., Zhang, L., Huang, X., Wang, J., Liu, Z., Qin, W., et al. (2022) · eLife · doi:10.7554/elife.71880 · Cited by 180
Connecting omics signatures and revealing biological mechanisms with iLINCS
Pilarczyk, M., Fazel-Najafabadi, M., Kouril, M., Shamsaei, B., Vasiliauskas, J., Niu, W., Mahi, N., Zhang, L., Clark, N. A., Ren, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32205-3 · Cited by 153
Self-citationFröhlich, F., Kessler, T., Weindl, D., Shadrin, A., Schmiester, L., Hache, H., Muradyan, A., Schütte, M., Lim, J.-H., Heinig, M., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.013 · Cited by 143
“Such datasets are currently not available from published comprehensive screens but are being collected in ongoing efforts such as the Library of Integrated Network-Based Cellular Signature (Koleti et al., 2018) program.”
MethodSigCom LINCS: data and metadata search engine for a million gene expression signatures
Evangelista, J. E., Clarke, D. J. B., Xie, Z., Lachmann, A., Jeon, M., Chen, K., Jagodnik, K. M., Jenkins, S. L., Kuleshov, M. V., Wojciechowicz, M. L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac328 · Cited by 128
Self-citationDrug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 116
Self-citationNetwork-based multi-omics integrative analysis methods in drug discovery: a systematic review
Jiang, W., Ye, W., Tan, X., & Bao, Y. (2025) · BioData Mining · doi:10.1186/s13040-025-00442-z · Cited by 164
Systems Pharmacology: Defining the Interactions of Drug Combinations
van Hasselt, J. G. C., & Iyengar, R. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021511 · Cited by 111
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Stathias, V., Jermakowicz, A. M., Maloof, M. E., Forlin, M., Walters, W., Suter, R. K., Durante, M. A., Williams, S. L., Harbour, J. W., Volmar, C.-H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07659-z · Cited by 99
Self-citationA cross-study analysis of drug response prediction in cancer cell lines
Xia, F., Allen, J., Balaprakash, P., Brettin, T. S., García–Cardona, C., Clyde, A., Cohn, J. D., Doroshow, J. H., Duan, X., Dubinkina, V. B., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab356 · Cited by 123
Sinkala, M., Nkhoma, P., Mulder, N., & Martin, D. P. (2021) · Communications Biology · doi:10.1038/s42003-020-01552-6 · Cited by 97
Systems biology based drug repositioning for development of cancer therapy
Turanlı, B., Altay, Ö., Borén, J., Türkez, H., Nielsen, J., Uhlén, M., Arğa, K. Y., & Mardinoğlu, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.020 · Cited by 92
Integrating knowledge and omics to decipher mechanisms via large‐scale models of signaling networks
Garrido‐Rodriguez, M., Zirngibl, K., Ivanova, O., Lobentanzer, S., & Saez‐Rodriguez, J. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211036 · Cited by 70
A multimodal deep learning-based drug repurposing approach for treatment of COVID-19
Hooshmand, S. A., Zarei Ghobadi, M., Hooshmand, S. E., Azimzadeh Jamalkandi, S., Alavi, S. M., & Masoudi-Nejad, A. (2021) · Molecular Diversity · doi:10.1007/s11030-020-10144-9 · Cited by 70
Drug target ontology to classify and integrate drug discovery data
Lin, Y., Mehta, S., Küçük-McGinty, H., Turner, J. P., Vidovic, D., Forlin, M., Koleti, A., Nguyen, D.-T., Jensen, L. J., Guha, R., et al. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0161-x · Cited by 69
Self-citationAdvancing precision oncology with AI-powered genomic analysis
Srivastava, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591696 · Cited by 85
Signature-based approaches for informed drug repurposing: targeting CNS disorders
Shukla, R., Henkel, N., Alganem, K., Hamoud, A.-R. A., Reigle, J. K., Alnafisah, R. S., Eby, H., Imami, A. S., Creeden, J. F., Miruzzi, S. A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0752-6 · Cited by 71
Self-citationComputational Drug Repositioning: Current Progress and Challenges
Ko, Y. (2020) · Applied Sciences · doi:10.3390/app10155076 · Cited by 67
Connectivity Mapping: Methods and Applications
Keenan, A. B., Wojciechowicz, M. L., Wang, Z., Jagodnik, K. M., Jenkins, S. L., Lachmann, A., & Ma’ayan, A. (2019) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-072018-021211 · Cited by 56
Self-citationRegan, K., Xu, J., DiVincenzo, M. J., Duggan, M. C., Shakya, R., Na, R., Carson, W. E., Payne, P., & Li, F. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0085-4 · Cited by 68
Zhong, F., Wu, X., Yang, R., Li, X., Wang, D., Fu, Z., Liu, X., Wan, X., Yang, T., Fan, Z., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00885-0 · Cited by 56
Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
Lemus, E. H., & Martínez-García, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.605680 · Cited by 61
Blood-based multi-tissue gene expression inference with Bayesian ridge regression
Xu, W., Liu, X., Leng, F., & Li, W. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa239 · Cited by 49
Saqib, U., Kelley, T. T., Panguluri, S. K., Liu, D., Savai, R., Baig, M. S., & Schürer, S. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01201 · Cited by 57
Self-citationConnectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Sullivan, C. R., Mielnik, C. A., O'Donovan, S. M., Funk, A. J., Bentea, E., DePasquale, E. A. K., Alganem, K., Wen, Z., Haroutunian, V. H., Katsel, P., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1390-4 · Cited by 52
Self-citationChidambaran, V., Zhang, X., Geisler, K. J., Stubbeman, B. L., Chen, X., Weirauch, M. T., Meller, J., & Ji, H. (2019) · Journal of Pain · doi:10.1016/j.jpain.2018.12.008 · Cited by 43
Self-citationMicrobial and genetic-based framework identifies drug targets in inflammatory bowel disease
Wang, Z., Guo, K., Gao, P., Pu, Q., Lin, P., Qin, S., Xie, N., Hur, J., Li, C. L., Huang, C., et al. (2021) · Theranostics · doi:10.7150/thno.59196 · Cited by 43
Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
To, K. K. W., & Cho, W. C. S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220214104530 · Cited by 43
Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
Feng, F., Shen, B., Mou, X., Li, Y., & Li, H. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.03.007 · Cited by 55
Transformational machine learning: Learning how to learn from many related scientific problems
Olier, I., Orhobor, O. I., Dash, T., Davis, A. M., Soldatova, L., Vanschoren, J., & King, R. D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108013118 · Cited by 43
Getting Started with LINCS Datasets and Tools
Xie, Z., Kropiwnicki, E., Wojciechowicz, M. L., Jagodnik, K. M., Shu, I., Bailey, A., Clarke, D. J. B., Jeon, M., Evangelista, J. E., Kuleshov, M. V., et al. (2022) · Current Protocols · doi:10.1002/cpz1.487 · Cited by 42
Self-citationSustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center
Stathias, V., Koleti, A., Vidović, D., Cooper, D. J., Jagodnik, K. M., Terryn, R., Forlin, M., Chung, C., Torre, D., Ayad, N. G., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.117 · Cited by 36
Self-citationLee, Y.-F., Lee, C., Lai, L., Tsai, M., Lu, T., & Chuang, E. Y.-Y. (2018) · Database · doi:10.1093/database/bax101 · Cited by 35
Editorial: Drug Repositioning: Current Advances and Future Perspectives
Nishimura, Y., & Hara, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01068 · Cited by 33
Drug repositioning for cancer in the era of AI, big omics, and real-world data
Wieder, R., & Adam, N. R. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103730 · Cited by 42
Wang, Q., Karvelsson, S. T., Kotronoulas, A., Guðjónsson, Þ., Halldórsson, S., & Rolfsson, Ó. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100185 · Cited by 34
Kim, I., Jang, H.-Y., Kim, J. H., Kim, M. G., Kim, S., & Oh, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39228-9 · Cited by 35
RetractedLooking at the BiG picture: incorporating bipartite graphs in drug response prediction
Hostallero, D. E., Li, Y., & Emad, A. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac383 · Cited by 35
taweraqi, N. A., & King, R. D. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04787-8 · Cited by 29
Extrapolation is not the same as interpolation
Wang, Y., & King, R. D. (2024) · Machine Learning · doi:10.1007/s10994-024-06591-2 · Cited by 34
Schaniel, C., Dhanan, P., Hu, B., Xiong, Y., Raghunandan, T., Gonzalez, D. M., Dariolli, R., D'Souza, S. L., Yadaw, A. S., Hansen, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.005 · Cited by 26
Self-citationValidating Small Molecule Chemical Probes for Biological Discovery
Vu, V., Szewczyk, M. M., Nie, D. Y., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105344 · Cited by 28
piNET: a versatile web platform for downstream analysis and visualization of proteomics data
Shamsaei, B., Chojnacki, S., Pilarczyk, M., Najafabadi, M. F., Niu, W., Chen, C., ROSS, K. E., Matlock, A. D., Muhlich, J. L., Chutipongtanate, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa436 · Cited by 26
Self-citationTian, S., Liao, X., Cao, W., Wu, X., Chen, Z., Lu, J., Wang, Q., Zhang, J., Chen, L., & Zhang, W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.08.017 · Cited by 27
Katayama, S., Panelius, J., Koskenmies, S., Skoog, T., Mähönen, K., Kisand, K. E., Bondet, V., Duffy, D., Krjutškov, K., Kere, J., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.035 · Cited by 26
Data considerations for predictive modeling applied to the discovery of bioactive natural products
Xue, H. T., Stanley-Baker, M., Kong, A. W., Li, H., & Goh, W. W. B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.05.009 · Cited by 25
Meiners, F., Hinz, B., Boeckmann, L., Secci, R., Sueto, S. O. B., Kuepfer, L., Fuellen, G., & Barrantes, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-55870-4 · Cited by 22
Artificial intelligence and anti-cancer drugs' response
Long, X., Sun, K., Lai, S., Liu, Y., Su, J., Chen, W., Liu, R., He, X., Zhao, S., & Huang, K. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.009 · Cited by 24
Evaluating the consistency of large-scale pharmacogenomic studies
Rahman, R., Dhruba, S. R., Matlock, K., Niz, C. D., Ghosh, S., & Pal, R. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby046 · Cited by 24
L1000 Viewer: A Search Engine and Web Interface for the LINCS Data Repository
Musa, A., Tripathi, S., Dehmer, M., & Emmert‐Streib, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00557 · Cited by 22
A network-based trans-omics approach for predicting synergistic drug combinations
Iida, M., Kuniki, Y., Yagi, K., Goda, M., Namba, S., Takeshita, J., Sawada, R., Iwata, M., Zamami, Y., Ishizawa, K., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00571-2 · Cited by 22
Disulfiram in glioma: Literature review of drug repurposing
Zhong, S., Liu, S., Shi, X., Zhang, X., Li, K., Liu, G., Li, L., Tao, S., Zheng, B., Sheng, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.933655 · Cited by 24
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities
Shah, I., Bundy, J., Chambers, B., Everett, L. J., Haggard, D., Harrill, J., Judson, R. S., Nyffeler, J., & Patlewicz, G. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00245 · Cited by 19
KInhibition: A Kinase Inhibitor Selection Portal
Bello, T., & Gujral, T. S. (2018) · iScience · doi:10.1016/j.isci.2018.09.009 · Cited by 20
Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array
Koch, R. J., Barrette, A. M., Stern, A. D., Hu, B., Bouhaddou, M., Azeloglu, E. U., Iyengar, R., & Birtwistle, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-29436-0 · Cited by 20
Quan, P., Wang, K., Shi, Y., Wen, S., Wei, C., Zhang, X., Cao, J., & Yao, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-92701-2 · Cited by 24
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome
Bhattacharyya, R., Ha, M. J., Liu, Q., Akbani, R., Liang, H., & Baladandayuthapani, V. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00140 · Cited by 18
L2S2: chemical perturbation and CRISPR KO LINCS L1000 signature search engine
Marino, G. B., Evangelista, J. E., Clarke, D. J. B., & Ma’ayan, A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf373 · Cited by 25
Self-citationMulti-objective distributed Web service composition—A link-dominance driven evolutionary approach
Sadeghiram, S., Ma, H., & Chen, G. (2023) · Future Generation Computer Systems · doi:10.1016/j.future.2023.01.001 · Cited by 17
Han, S., Lee, J. E., Kang, S., So, M., Jin, H. K., Lee, J. H., Baek, S., Jun, H., Kim, T. Y., & Lee, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae035 · Cited by 19
Durai, P., Ko, Y., Pan, C., & Park, K. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03643-x · Cited by 19
Li, S., Zhang, F., Xiao, X., Guo, Y., Wen, Z., Li, M., & Pu, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634097 · Cited by 18
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
Kim, I., Kim, J. H., & Oh, J. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00661 · Cited by 16
Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
Tsakaneli, A., & Williams, O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.741413 · Cited by 19
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Imami, A. S., McCullumsmith, R. E., & O'Donovan, S. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01724-w · Cited by 18
Kumar, H., Mazumder, S., Chakravarti, S., Sharma, N., Mukherjee, U. K., Kumar, S. K., Baughn, L. B., Ness, B. G. V., & Mitra, A. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00636-2 · Cited by 14
Systematic computational strategies for identifying protein targets and lead discovery
Kataria, A., Srivastava, A., Singh, D. D., Haque, S., Han, I., & Yadav, D. K. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00223g · Cited by 19
Ahmed, M., Lai, T. H., Kim, W., & Kim, D. R. (2021) · Cancers · doi:10.3390/cancers13236098 · Cited by 15
Salame, N., Fooks, K., El-Hachem, N., Bikorimana, J., Mercier, F., & Rafei, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.852143 · Cited by 18
Imbalanced regression using regressor-classifier ensembles
Orhobor, O. I., Grinberg, N. F., Soldatova, L., & King, R. D. (2022) · Machine Learning · doi:10.1007/s10994-022-06199-4 · Cited by 15
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy
To, K. K. W., & Cho, W. C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082166 · Cited by 18
Informatics Approaches for Harmonized Intelligent Integration of Stem Cell Research
Finkelstein, J., Parvanova, I., & Zhang, F. (2020) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s237361 · Cited by 20
COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts
Välikangas, T., Junttila, S., Rytkönen, K. T., Kukkonen-Macchi, A., Suomi, T., & Elo, L. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929887 · Cited by 13
Huang, L., Yeung, W., Wang, Y., Cheng, H., Venkat, A., Li, S., Ma, P., Rasheed, K., & Kannan, N. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03842-6 · Cited by 16
Datasets2Tools, repository and search engine for bioinformatics datasets, tools and canned analyses
Torre, D., Krawczuk, P., Jagodnik, K. M., Lachmann, A., Wang, Z., Wang, L., Kuleshov, M. V., & Ma’ayan, A. (2018) · Scientific Data · doi:10.1038/sdata.2018.23 · Cited by 14
Self-citationDark kinase annotation, mining, and visualization using the Protein Kinase Ontology
Soleymani, S., Gravel, N., Huang, L.-C., Yeung, W., Bozorgi, E., Bendzunas, N. G., Kochut, K. J., & Kannan, N. (2023) · PeerJ · doi:10.7717/peerj.16087 · Cited by 13
Grand Challenges for Artificial Intelligence in Molecular Medicine
Emmert‐Streib, F. (2021) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2021.734659 · Cited by 14
Ong, E., Xie, J., Ni, Z., Liu, Q., Sarntivijai, S., Lin, Y., Cooper, D. J., Terryn, R., Stathias, V., Chung, C., et al. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1981-5 · Cited by 12
Self-citationiGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research
Chen, X., Guo, Y., & Chen, X. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.11.011 · Cited by 13
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency
Matlock, A. D., Vaibhav, V., Holewinski, R. J., Venkatraman, V., Dardov, V. J., Manalo, D.-M., Shelley, B., Ornelas, L., Bañuelos, M. G., Mandefro, B., et al. (2023) · Scientific Data · doi:10.1038/s41597-022-01687-7 · Cited by 11
Learning important features from multi-view data to predict drug side effects
Liang, X., Zhang, P., Li, J., Fu, Y., Qu, L., Chen, Y., & Chen, Z. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0402-3 · Cited by 13
Drug repurposing for Basal breast cancer subpopulations using modular network signatures
Coria-Rodríguez, H., Ochoa, S., de Anda‐Jáuregui, G., & Lemus, E. H. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107902 · Cited by 11
Identification of Novel Analgesics Through a Drug Repurposing Strategy
Gazerani, P. (2019) · Pain Management · doi:10.2217/pmt-2018-0091 · Cited by 12
Aguayo‐Orozco, A., Brunak, S., & Taboureau, O. (2020) · Computational Toxicology · doi:10.1016/j.comtox.2020.100147 · Cited by 15
Drug repositioning prediction for psoriasis using the adverse event reporting database
Ko, M., Oh, J. M., & Kim, I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1159453 · Cited by 13
Cooper, D. J., & Schürer, S. C. (2019) · Molecules · doi:10.3390/molecules24081604 · Cited by 12
Self-citationBioinformatics Tools and Resources for Cancer Immunotherapy Study
Palmisano, A., Krushkal, J., Li, M., Fang, J., Sonkin, D., Wright, G. W., Yee, L. M., Zhao, Y., & McShane, L. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_29 · Cited by 9
IUPHAR review – Data-driven computational drug repurposing approaches for opioid use disorder
Gao, Z., Ding, P., & Xu, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106960 · Cited by 11
Computational drug repurposing for viral infectious diseases: a case study on monkeypox
Saha, S., Chatterjee, P., Nasipuri, M., Basu, S., & Chakraborti, T. (2024) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad058 · Cited by 9
Baek, I., Rhim, J. W., Park, K., & Kim, K. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03498-8 · Cited by 8
Pawar, V. A., Tyagi, A., Verma, C., Sharma, K. P., Ansari, S., Mani, I., Srivastva, S. K., Shukla, P. K., Kumar, A., & Kumar, V. (2023) · PubMed Central · Cited by 12
CORN—Condition Orientated Regulatory Networks: bridging conditions to gene networks
Leung, R. W. T., Jiang, X., Zong, X., Zhang, Y., Hu, X., Hu, Y., & Qin, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac402 · Cited by 10
Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer
Wang, Z., Mehmood, A., Yao, J., Zhang, H., Wang, L., Al-Shehri, M., Kaushik, A. C., & Wei, D. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01007-1 · Cited by 8
Self-citationKinome-Wide Activity Classification of Small Molecules by Deep LearningPreprint
Allen, B. K., Ayad, N. G., & Schürer, S. C. (2019) · SSRN Electronic Journal · doi:10.1101/512459 · Cited by 8
Self-citationDrug repurposing using meta-analysis of gene expression in Alzheimer’s disease
Jang, H. Y., Oh, J. M., & Kim, I. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.989174 · Cited by 8
Metadata
- Authors
- Koleti, A., Terryn, R., Stathias, V., Chung, C., Cooper, D. J., Turner, J. P., Vidović, D., Forlin, M., Kelley, T. T., D’Urso, A., Allen, B. K., Torre, D., Jagodnik, K. M., Wang, L., Jenkins, S. L., Mader, C., Niu, W., Fazel, M., Mahi, N., Pilarczyk, M., Clark, N., Shamsaei, B., Meller, J., Vasiliauskas, J., Reichard, J., Medvedovic, M., Ma’ayan, A., Pillai, A., & Schürer, S. C.
- Affiliations
- University of Miami (US)
- National Institutes of Health (US)
- Corresponding author
- Schürer, Stephan C
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-13
- Volume
- 46
- Issue
- D1
- Pages
- D558-D566
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5753343
- OpenAlex
- W2768921712
- Cited by
- 193
- References
- 20
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 15 · 2023: 20 · 2022: 28 · 2021: 20 · 2020: 26 · 2019: 22 · 2018: 17 · 2017: 4
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- University of Miami
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U54HL127624, T32HL007824)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- LINCS, data portal, data integration, data standards, data annotation, web interface, data curation, systems biology
- MeSH terms
- Metadata, Cell Biology, Humans, Software, User-Computer Interface, Databases, Factual, Computational Biology, Databases, Genetic, Proteomics, Systems Biology, Epigenomics, Data Curation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.